Quantcast

LEGAL NEWSLINE

Thursday, March 28, 2024

Shareholder alleges Allergan violated federal securities law

General court 10

shutterstock.com

LOS ANGELES (Legal Newsline) — A shareholder is suing a pharmaceutical company and its officers, alleging negligent misrepresentation and violation of federal law.

Lina Arslanian filed a class action lawsuit, individually and on behalf of all others similarly situated, Nov. 4 in U.S. District Court for the Central District of California against Allergan PLC, Actavis PLC, Paul M. Bisaro, Robert Todd Joyce, Brenton L. Saunders and Maria Teresa Hilado, alleging they made false statements regarding the company's fiscal year.

According to the complaint, Arslanian suffered monetary damages from purchasing securities at inflated prices. The plaintiff alleges the defendants made false and misleading statements in order to artificially inflate securities prices.

Arslanian seeks trial by jury, damages, interest, all legal fees and any other relief the court deems just. She is represented by attorney Laurence M. Rosen of The Rosen Law Firm PA in Los Angeles.

U.S. District Court for the Central District of California Case number 2:16-cv-08254-R-FFM

More News